Table 1. Cell-based screening assay for candidate drugs.
Cell type(s) |
Model |
Active compounds |
References |
SPR: surface plasmon resonance; MEFs: NF1-deficient mouse embryonic fibroblasts | |||
MCF-7 Cells/ OR6M1-expressing cell lines |
SPR chip immobilized cells. A modified carboxymethyl dextran sensor chip |
Anthraquinone, rutin |
Choi et al. 2021 |
DNA-PKcs and OCT4 - expressing HEK-293FT cells/ MK2 and OCT4 expressing NCI-H82 cells |
384-well plate. Two-step method. Exogenously expressing proteinsin cancer cells as first step |
A cardioglycoside and an isocarbostyril alkaloid, cholesterol-based structures (three compounds) |
Mohiuddin et al. 2021 |
Vero E6 cells |
96-well plates. Transfected 2-E plasmids after compounds pre-incubated |
34 hits with cell protection activity |
Wang et al. 2021 |
HeLa cells |
24-well plates. Treated with compounds followed by labeling of the intracellular Hsp90. Analysis with in-gel fluorescence after cell lysis |
157 compounds. Morin |
Ueda et al. 2020 |
COS7 cells |
Clean glass. Single-protein tracking in a living cell. Effects are evaluated by diffusion coefficient shift using fluorescence microscopy |
Hyperoside for EGFR and ErbB2. DiAB-141 and 2”-O-acetylvitexin for ErbB3 |
Kim et al. 2021 |
COS-7 cells |
96-well plates. Cells seeded in monolayer and molecules added to the medium |
Blebbistatin, para-aminoblebbistatin, para-nitroblebbistatin, jasplakinolide, cytochalasin D, swinholide A |
Radnai et al. 2020 |
HEK293:FLP-InT-REx-BiFC#20 cells |
384-well clear-bottom, black-walled microplate. Cells seeded in monolayer and molecules added to the medium |
6 compounds. Isocotoin |
Xu et al. 2020 |
Vero E6/A549/Huh7/ LN-18 cells |
6-well plate format and 96-well plate. Cells infected viral dilutions. Cells seeded in monolayer and antivirals in infection medium added to cells |
Sofosbuvir and ribavirin |
Vicenti et al. 2020 |
HEp-2/ A549/293T cells |
96-well plate. Cells seeded in monolayer and molecules and virus added to the medium |
Laby A1/A2 |
Blockus et al. 2020 |
Human embryonic stem cells/ Fibroblasts from healthy donors and patients |
384-well plates. Cells seeded in monolayer and molecules added to the medium |
CUDC-907 |
Kase et al. 2021 |
HpeG2/ HeLa cells |
Culture chamber. 3D electric cell/matrigel-substrate impedance sensing chip. Cells seeded in prechilled matrigel solution and generated 3D structure |
Taxol, cisplatin, sorafenib |
Pan et al. 2019 |
HeLa cells |
96-well plates and 384-well plates. Cells seeded in monolayer and molecules added to the medium followed with added viral solution |
11 compounds. Gemcitabine |
Zhang et al. 2017 |
MEFs |
96-well plates. Cells seeded in monolayer and molecules added to the medium |
Cantharidin, Nifedipine |
Semenova et al. 2017 |
HeLa cells |
384-well clear-bottomed black plates. Cells seeded in monolayer and molecules added to the medium |
18 compounds |
Hajjar et al. 2017 |
MDA-MB-231 breast cancer cells/ HUVECs |
96-well plates. Cells seeded in monolayer and extracts added to the medium |
Cirsimaritin, Cirsium japonicum extract, cirsimaritin |
Yeon Park et al. 2017 |
HepG2 ARE reporter cells |
384 well pate format. Cells seeded in monolayer and molecules added to the medium |
AZ-628, PHA-767491, SL-327, PAC-1, pifithrin-α, vitamin B12 |
Liu et al. 2018a |
MC3T3-E1-OSE cells |
96-well plates. Cells seeded in monolayer and molecules added to the medium |
4 compounds. T63 |
Zhao et al. 2017 |
ARPE-19 cells |
96-well plate. Cells seeded in monolayer and molecules added to the medium |
47 compounds |
Maruyama et al. 2018 |
MG-63 cells |
96-well plate. Cells seeded in monolayer and molecules added to the medium |
42 compounds |
Wang et al. 2020a |
A549 cells |
384-well plates. Cells seeded in monolayer and infected with DENV1-4, and treated immediately with compounds |
(S)-29 |
Kounde et al. 2017 |